CVE-2024-45096

CVE-2024-45096 is a medium-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-548.

Key facts

Description

IBM Aspera Faspex 5.0.0 through 5.0.9 could allow a user with access to the package to obtain sensitive information through a directory listing.

Frequently asked questions

What is CVE-2024-45096?
IBM Aspera Faspex 5.0.0 through 5.0.9 could allow a user with access to the package to obtain sensitive information through a directory listing.
How severe is CVE-2024-45096?
CVE-2024-45096 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2024-45096 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (29th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-45096?
CVE-2024-45096 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-45096?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-45096 have an EU (EUVD) identifier?
Yes. CVE-2024-45096 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-41303.
When was CVE-2024-45096 published?
CVE-2024-45096 was published on 2024-09-05 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Ibm Aspera Faspex

All CVEs affecting Ibm Aspera Faspex →

Other CWE-548 vulnerabilities

Browse all CWE-548 vulnerabilities →